F32
Conditions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Previously diagnosed with depression (with or without comorbidities) - In-patient at the Alexianer Zentrum für seelische Gesundheit Aachen OR - Patient at the internal "Psychiatrische Institutsambulanz" - PIA - in an out-patient setting - signed informed consent - Speak and understand the German language (at lest B2 proficiency) - In procession of a smartphone or tablet (device that is able to download the requested apps)
Exclusion criteria
Exclusion criteria: - Acute psychological crisis/ psychiatric emergency (e.g. suicidal) - No suitable cognitive or physical abilities to fulfil the minimum requirements to participate in this study and to be compliant to the requirements - Not in possession of a smartphone
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary objective is to evaluate the feasibility and acceptability of an RM system among patients with depression. To this end, patient compliance with the system and the overall user experience will be analyzed and assessed. The primary endpoint measures patient compliance with the use of the RM system. It is recorded as “daily adherence,” i.e., as the percentage of days with valid data. This figure is calculated as follows: the number of days with at least 80% of data fully recorded divided by the total number of days during the monitoring period. | — |
Secondary
| Measure | Time frame |
|---|---|
| Further objectives are: • Evaluate patient compliance with the RM system in the depression population, as measured by daily adherence, frequency of use and completeness of transmitted data. • Evaluate the feasibility of an RM system in a depression population based on the user experience from the perspective of all healthcare stakeholders, including patients, primary care providers, and specialists • To assess the acceptability and usability of the RM system among patients and providers with the help of the Mobile Anwendung Rating Skala (MARS) • To assess patient experience and satisfaction through testimonials and structured feedback, including the care path questionnaire. • Assess the practical implementation of defined roles within the hybrid care pathway, specifically evaluating how responsibilities are carried out by primary and secondary care providers. • Evaluate the quality of collaboration and communication between primary and secondary care professionals throughout the care process. • Examine cross-border care dynamics, including whether patients experience improved outcomes and whether collaboration between healthcare providers across borders is enhanced. • Evaluate the eHealth literacy of depression patients with help of the eHealth Literacy Questionnaire (eHLQ) at the beginning of the study, and compare this with their literacy at the end of study participation Data Collection: • Patient experience and satisfaction (assessed using the MARS questionnaire, administered in this setting as an interview with patients, and the CARE Path questionnaire) • Healthcare professional experience and satisfaction (assessed using the CARE Path questionnaire) • Testimonials from patients and healthcare professionals (from conversations during rounds or throughout the study period) • Wear time: Number of measurements taken divided by the number of measurements to be taken. (for the measurement with the highest frequency) • eHealth Literacy | — |
Countries
Germany
Contacts
Universiteit Hasselt - Campus Diepenbeek